Vr Adviser, LLC Milestone Pharmaceuticals Inc. Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.67 - $3.39 $2.14 Million - $4.35 Million	-1,283,764 Reduced 58.12%	925,048 $1.54 Million
Q4 2022 May 15, 2023	SELL	$3.53 - $9.5 $765,745 - $2.06 Million	-216,925 Reduced 8.94%	2,208,812 $8.75 Million
Q4 2022 Feb 14, 2023	SELL	$3.53 - $9.5 $765,745 - $2.06 Million	-216,925 Reduced 8.94%	2,208,812 $8.75 Million
Q3 2022 May 15, 2023	BUY	$5.86 - $9.43 $1.27 Million - $2.05 Million	216,925 Added 9.82%	2,425,737 $19.2 Million
Q3 2022 Nov 14, 2022	BUY	$5.86 - $9.43 $14.2 Million - $22.9 Million	2,425,737 New	2,425,737 $22.3 Million

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $70.8M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.